Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligands

被引:56
|
作者
Nemeth, Krisztian [1 ]
Mayer, Balazs [1 ]
Mezey, Eva [1 ]
机构
[1] NIDCR, NIH, CSDB, Bethesda, MD 20892 USA
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2010年 / 88卷 / 01期
关键词
Adult stem cells; TLR; Bone marrow; Immunology; Infectiology; Antiviral; MESENCHYMAL STEM-CELLS; RESPONSES; TRANSPLANTATION; SEPSIS; VIRUS;
D O I
10.1007/s00109-009-0523-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Bone marrow-derived stromal cells (BMSCs, or as they are frequently referred to as mesenchymal stem cells) have been long known to support hematopoiesis and to regenerate bone, cartilage, and adipose tissue. In the last decade, however, a vast amount of data surfaced in the literature to suggest new roles for these cells including tissue regeneration and immunomodulation. A great number of review articles appeared that summarize these new data and focus on different aspects of the physiology of these cells. In this present short review, we will try to summarize the available data based on both mouse and human cells describing how the function of BMSCs might be affected by an infectious environment. These data strongly support the idea that different toll-like receptor ligands can lead to substantial changes in the function of BMSCs that affect their proliferation, apoptosis, migration, and their production and release of immunomodulatory factors.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 50 条
  • [31] Expression and functions of Toll-like receptor 2
    Espevik, T
    Flo, TH
    Halaas, O
    Torp, S
    Lien, E
    FASEB JOURNAL, 2001, 15 (04): : A649 - A649
  • [32] Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands
    Hussein, Waleed M.
    Choi, Phil M.
    Zhang, Cheng
    Su, Mei
    Sierecki, Emma
    Johnston, Wayne
    Fagan, Vincent
    Alexandrov, Kirill
    Skwarczynski, Mariusz
    Gambin, Yann
    Toth, Istvan
    Simerska, Pavla
    CURRENT DRUG DELIVERY, 2017, 14 (07) : 935 - 943
  • [33] Prophylactic and therapeutic implications of toll-like receptor ligands
    Hedayat, Mona
    Takeda, Kiyoshi
    Rezaei, Nima
    MEDICINAL RESEARCH REVIEWS, 2012, 32 (02) : 294 - 325
  • [34] Simple synthetic toll-like receptor 2 ligands
    Abdel-Aal, Abu-Baker M.
    Al-Isae, Kalifa
    Zaman, Mehfuz
    Toth, Istvan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5863 - 5865
  • [35] Endogenous toll-like receptor ligands and their biological significance
    Yu, Li
    Wang, Liantang
    Chen, Shangwu
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (11) : 2592 - 2603
  • [36] Screening of endogenous ligands for Toll-like receptor 3
    Yang, EJ
    Shin, JS
    Choi, IH
    FASEB JOURNAL, 2005, 19 (04): : A376 - A376
  • [37] Toll-like receptor ligands-invaders or saboteurs?
    Corr, M.
    Choe, J.
    Uc, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 44 - 44
  • [38] Immunostimulatory properties of Toll-like receptor ligands in chickens
    St Paul, Michael
    Brisbin, Jennifer T.
    Abdul-Careem, Mohamed Faizal
    Sharif, Shayan
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2013, 152 (3-4) : 191 - 199
  • [39] METABOLIC REPROGRAMMING OF MACROPHAGES WITH TOLL-LIKE RECEPTOR LIGANDS
    Fensterheim, B.
    Trenary, I.
    Young, J.
    Sherwood, E.
    SHOCK, 2015, 43 (06): : 29 - 30
  • [40] Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands
    Rumio, Cristiano
    Sommariva, Michele
    Sfondrini, Lucia
    Palazzo, Marco
    Morelli, Daniele
    Vigano, Laura
    De Cecco, Loris
    Tagliabue, Elda
    Balsari, Andrea
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (03) : 1107 - 1113